老年患者静脉血栓栓塞症的预防

doi:10.16352/j.issn.1001-6325.2024.07.0916

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (7): 916-920.doi: 10.16352/j.issn.1001-6325.2024.07.0916

• 特邀专题：静脉血栓栓塞症 • 上一篇下一篇

老年患者静脉血栓栓塞症的预防

丁梦希¹, 王春梅^2*

首都医科大学宣武医院 1.全科医学科;
2.重症医学科,北京 100053

收稿日期:2024-04-22 修回日期:2024-05-21 出版日期:2024-07-05 发布日期:2024-06-26
通讯作者: ^*wangchunmei@xwhosp.org
基金资助:
首都卫生发展科研专项(首发2022-2-2016)

Prevention of venous thromboembolism in elderly patients

DING Mengxi¹, WANG Chunmei^2*

1. Department of General Medicine;
2. Department of Intensive Care Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Received:2024-04-22 Revised:2024-05-21 Online:2024-07-05 Published:2024-06-26
Contact: ^*wangchunmei@xwhosp.org

摘要/Abstract

摘要： 静脉血栓栓塞症(venous thromboembolism,VTE)是常见病,发病率和病死率高。在老年患者VTE发病率更高、病死率更高,年龄增加导致血栓标志物D-二聚体数值也增加,应用D-二聚体数值筛查VTE需要调整诊断阈值,年龄增加也是抗凝预防后出血的高危因素;另外,老年患者抗凝预防后仍有VTE发生;老年患者抗凝预防VTE是否需要监测,年龄与VTE复发关系尚无定论,深入研究老年预防VTE,并探索创新的VTE预防策略,是未来研究工作的方向。

关键词: 老年患者, 静脉血栓栓塞症, 预防

Abstract: Venous thromboembolism (VTE) is a common disease with high morbidity and mortality. The incidence and mortality of VTE are higher in elderly patients and increased level of D-dimer, a thrombosis marker is positively related with age. Therefore, the diagnostic threshold needs to be adjusted to screen VTE with D-dimer level. Elderly patients may still have VTE after implementation of anticoagulant prevention, and increasing age is a high risk factor for bleeding after anticoagulant prevention. Whether elderly patients need to be monitored for anticoagulant prevention of VTE, and the relationship between age and VTE recurrence remains to be determined. In-depth research on the prevention of VTE in elderly patients and exploration of innovative VTE prevention strategies may orient future research.

Key words: elderly patient, venous thromboembolism, prevention

中图分类号:

R543.6

丁梦希, 王春梅. 老年患者静脉血栓栓塞症的预防[J]. 基础医学与临床, 2024, 44(7): 916-920.

DING Mengxi, WANG Chunmei. Prevention of venous thromboembolism in elderly patients[J]. Basic & Clinical Medicine, 2024, 44(7): 916-920.

参考文献

[1]Zhang X, Cai Q, Wang X, et al. Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE)[J]. J Thromb Thrombolysis, 2021,52:863-871.
[2]Nicholson M, Chan N, Bhagirath V, et al. Prevention of venous thromboembolism in 2020 and beyond[J]. J Clin Med, 2020,9.doi: 10.3390/jcm9082467.
[3]Debnath J, Sharma V. Diagnosing pulmonary thromboembolism: concerns and controversies[J]. Med J Armed Forces India,2022,78:17-23.
[4]Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China[J]. Chest, 2019,155:342-353.
[5]Khan F, Tritschler T, Kahn S R, et al. Venous thromboembolism[J]. The Lancet, 2021,398:64-77.
[6]Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline[J]. Chest, 2022,162:e207-e243.
[7]熊雪, 李海磊, 舒春花, 等. 静脉血栓栓塞症风险评估工具的研究进展[J]. 中国当代医药, 2023,30:28-31.
[8]Chen X, Huang J, Liu J, et al. Venous thromboembolism risk factors and prophylaxis of elderly intensive care unit patients in a Chinese general hospital[J]. Ann Palliat Med, 2021,10:4453-4462.
[9]Lavon O, Tamir T. Evaluation of the padua prediction score ability to predict venous thromboembolism in Israeli non-surgical hospitalized patients using electronic medical records[J]. Sci Rep, 2022,12:6121.doi:10.1038/s41598-022-10209-9.
[10]Tritschler T, Aujesky D. Venous thromboembolism in the elderly: a narrative review[J]. Thromb Res, 2017,155:140-147.
[11]中国老年医学学会周围血管疾病管理分会, 赵纪春, 黄建华, 等. 老年人静脉血栓栓塞症防治中国专家共识[J]. 中国普外基础与临床杂志, 2023,30:1173-1187.
[12]中国老年医学学会重症医学分会, 浙江省重症医学临床医学研究中心. 老年重症患者静脉血栓栓塞症预防中国专家共识(2023)[J]. 中华危重病急救医学, 2023,35:561-572.
[13]Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment[J]. JAMA, 2018,320:1583-1594.
[14]De Pooter N, Brionne-François M, Smahi M, et al. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in patients with non-high pre-test probability: clinical performance and cost-effectiveness analysis[J]. J Thromb Haemost, 2021,19:1271-1282.
[15]Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for manage-ment of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients[J]. Blood Adv, 2018,2:3198-3225.
[16]李文欣, 李兴升. 老年患者抗凝药物使用进展[J]. 临床医学进展, 2021,11:5911-5916.
[17]Wang CM, Guo XF, Liu LM, et al. Prevention of deep vein thrombosis by panax notoginseng saponins combined with low-molecular-weight heparin in surgical patients[J]. Chin J Integr Med, 2022,28:771-778.
[18]傅日斌, 郑欣鹏, 林劲松, 等. 利伐沙班和低分子肝素在老年粗隆间骨折患者围手术期的应用效果分析[J]. 中国医药, 2024,19:93-96.
[19]Palareti G, Poli D. The prevention of venous thromboembolism recurrence in the elderly: a still open issue[J]. Expert Rev Hematol, 2018,11:903-909.
[20]Wang C, Ning YC, Song LP, et al. Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial[J]. BMJ Open, 2023,13:e69742.doi:10.1136/bmjopen-2022-069742.
[21]徐晓艳, 郭慧玲, 周伟明, 等. 静脉血栓栓塞复发危险因素分析及护理[J]. 血栓与止血学, 2020,26:679-682.

老年患者静脉血栓栓塞症的预防

Prevention of venous thromboembolism in elderly patients

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	谢芳菲, 李双玲, 王春梅. ICU危重患者静脉血栓栓塞症预防策略[J]. 基础医学与临床, 2024, 44(7): 906-911.
[2]	臧晗, 胡嫒, 许轩奇, 许力. 老年单侧全髋关节置换术围术期输血风险预测模型的构建[J]. 基础医学与临床, 2024, 44(1): 98-102.
[3]	张雨, 韩悦, 朱倩梅, 周会影, 苗煦涵, 姚晶曼, 刘子嘉, 申乐. 老年患者电视胸腔镜手术后肺部并发症的危险因素分析[J]. 基础医学与临床, 2023, 43(12): 1847-1851.
[4]	曹伟, 沈越, 马传荣. 预见性护理有利于稳定恶性梗阻性黄疸患者经PTCD术后情绪及降低术后并发症[J]. 基础医学与临床, 2021, 41(2): 250-253.
[5]	崔丽, 于壮. 胃复安预防羟考酮诱导的恶心呕吐的前瞻性观察[J]. 基础医学与临床, 2020, 40(9): 1201-1205.
[6]	杨玲, 杜雪平. 北京市西城区急性冠脉综合征住院患者的诊断治疗分析[J]. 基础医学与临床, 2020, 40(12): 1681-1685.
[7]	董德鑫李汉忠纪志刚石冰冰. 常见泌尿生殖系统肿瘤的病因学分析及预防[J]. 基础医学与临床, 2019, 39(6): 904-907.
[8]	吴遐高路幸兵. 库欣综合征所致高凝状态的研究进展[J]. 基础医学与临床, 2016, 36(1): 121-124.
[9]	周开国;何桂珍. 肿瘤恶病质的机制及可能的治疗[J]. 基础医学与临床, 2011, 31(1): 104-107.
[10]	李彦明陈允震张科峰刘海春裴保安. 生物蛋白胶联合明胶海绵预防兔硬膜外黏连[J]. 基础医学与临床, 2009, 29(6): 622-626.